Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276495 · ClinicalTrials.gov registry record · NA
Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?
A NA study of Pain Management, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT02276495: Completed NA study of Pain Management, sponsored by University of California, Irvine.
NCT02276495 is a NA study of Pain Management that has completed, run by University of California, Irvine. The registered enrollment target is 55 participants, below the 153-participant average among 31 other Pain Management trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02276495, a NA study of Pain Management, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine the effect of a single injection adductor canal block (ACB) on pain scores within 24 hours post total knee arthroplasty (TKA).
Primary Outcome
The primary outcome variable of interest is the median maximum pain score within 24 hours postoperative. Pain scores were rated on a scale from 0 - 10, with 0 being no discomfort/pain and 10 being worst imaginable pain.
Conditions Studied
Interventions
- OTHER ACB Control - 20 ml saline injection for ACB
- DRUG ACB Study - 20 ml 0.5% Ropivacaine for Adductor Canal Block
- DRUG Local infiltration - 100 mLs of a solution containing: Ropivacaine + Epinephrine + Ketorolac + Clonidine + 0.9% Normal saline
Study Locations (1)
California
- University of California, Irvine Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT02276495 record still lists
NCT02276495 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 153-participant average among 31 other Pain Management trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 3 interventions - of which ACB Control - 20 ml saline injection for ACB is the first listed.
NCT02276495 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02276495 about?
NCT02276495 is a clinical study titled "Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?". The purpose of the study is to determine the effect of a single injection adductor canal block (ACB) on pain scores within 24 hours post total knee arthroplasty (TKA).
What is the current status of trial NCT02276495?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-01-01. Estimated completion is 2024-09-30.
What conditions does trial NCT02276495 study?
This clinical trial studies the following conditions: Pain Management.
What interventions are being tested in trial NCT02276495?
The interventions under investigation include: ACB Control - 20 ml saline injection for ACB (OTHER), ACB Study - 20 ml 0.5% Ropivacaine for Adductor Canal Block (DRUG), Local infiltration - 100 mLs of a solution containing: Ropivacaine + Epinephrine + Ketorolac + Clonidine + 0.9% Normal saline (DRUG).
Who is sponsoring clinical trial NCT02276495?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02276495 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02276495's enrollment target sits among peer trials
55 23rd of 31 higher than 9 of 31 other Pain Management trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain Management trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
RECRUITING · NA
-
mHealth Intervention for Pain Self Management
RECRUITING · NA
-
Sensory Spinal Cord Stimulation
RECRUITING · NA
-
Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention
RECRUITING · NA
-
Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids
RECRUITING · NA
-
PEACE: Comparing Chronic Pain Treatment Options
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI